CORC  > 河南大学
Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
Bao Dengke[1]; Ba Yanna[2]; Zhou Feng[3]; Zhao Jing[4]; Yang Qi[5]; Ge Naijian[6]; Guo Xu[7]; Wu Zhenbiao[8]; Zhang Hongxin[9]; Yang Hushan[10]
刊名CANCER CHEMOTHERAPY AND PHARMACOLOGY
2016
卷号78期号:4页码:791-799
关键词Telomere length Mitochondrial DNA Hepatocellular carcinoma Prognosis
ISSN号0344-5704
DOIhttp://dx.doi.org/10.1007/s00280-016-3128-1
URL标识查看原文
收录类别SCI(E) ; PUBMED
WOS记录号WOS:000387275100015
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5199792
专题河南大学
作者单位1.[1]Institute of Pharmacy, Pharmaceutical College of Henan University, Kaifeng, 475004, Henan, China.
2.[2]Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shanxi, China.
3.[3]Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, Shanxi, China.
4.[4]Institute of Pharmacy, Pharmaceutical College of Henan University, Kaifeng, 475004, Henan, China.
5.[5]Institute of Pharmacy, Pharmaceutical College of Henan University, Kaifeng, 475004, Henan, China.
6.[6]Department of Radioactive Intervention, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, China.
7.[7]State Key Laboratory of Cancer Biology, Experimental Teaching Center of Basic Medicine, Fourth Military Medical University, 169 Changle West Road, Xi'an, 710032, Shanxi, China.
8.[8]Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shanxi, China.
9.[9]Department of Pain Treatment, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shanxi, China.
10.[10]Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
推荐引用方式
GB/T 7714
Bao Dengke[1],Ba Yanna[2],Zhou Feng[3],et al. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2016,78(4):791-799.
APA Bao Dengke[1].,Ba Yanna[2].,Zhou Feng[3].,Zhao Jing[4].,Yang Qi[5].,...&Xing Jinliang[12].(2016).Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.CANCER CHEMOTHERAPY AND PHARMACOLOGY,78(4),791-799.
MLA Bao Dengke[1],et al."Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization".CANCER CHEMOTHERAPY AND PHARMACOLOGY 78.4(2016):791-799.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace